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DOI 10.1186/s12968-015-0124-2RESEARCH Open AccessFeasibility of high-resolution quantitative
perfusion analysis in patients with heart failure
Eva Sammut1,3*, Niloufar Zarinabad1, Roman Wesolowski1, Geraint Morton1, Zhong Chen1, Manav Sohal1,
Gerry Carr-White2, Reza Razavi1 and Amedeo Chiribiri1Abstract
Background: Cardiac magnetic resonance (CMR) is playing an expanding role in the assessment of patients with
heart failure (HF). The assessment of myocardial perfusion status in HF can be challenging due to left ventricular
(LV) remodelling and wall thinning, coexistent scar and respiratory artefacts. The aim of this study was to assess the
feasibility of quantitative CMR myocardial perfusion analysis in patients with HF.
Methods: A group of 58 patients with heart failure (HF; left ventricular ejection fraction, LVEF ≤ 50%) and 33
patients with normal LVEF (LVEF >50%), referred for suspected coronary artery disease, were studied. All subjects
underwent quantitative first-pass stress perfusion imaging using adenosine according to standard acquisition
protocols. The feasibility of quantitative perfusion analysis was then assessed using high-resolution, 3 T kt perfusion
and voxel-wise Fermi deconvolution.
Results: 30/58 (52%) subjects in the HF group had underlying ischaemic aetiology. Perfusion abnormalities were
seen amongst patients with ischaemic HF and patients with normal LV function. No regional perfusion defect was
observed in the non-ischaemic HF group. Good agreement was found between visual and quantitative analysis
across all groups. Absolute stress perfusion rate, myocardial perfusion reserve (MPR) and endocardial-epicardial MPR
ratio identified areas with abnormal perfusion in the ischaemic HF group (p = 0.02; p = 0.04; p = 0.02, respectively).
In the Normal LV group, MPR and endocardial-epicardial MPR ratio were able to distinguish between normal and
abnormal segments (p = 0.04; p = 0.02 respectively). No significant differences of absolute stress perfusion rate or
MPR were observed comparing visually normal segments amongst groups.
Conclusions: Our results demonstrate the feasibility of high-resolution voxel-wise perfusion assessment in patients
with HF.
Keywords: Heart failure, Quantitative perfusion, Cardiovascular magnetic resonance, GadoliniumBackground
Despite recent advances in diagnosis and management,
heart failure (HF) remains a common cause of death and
morbidity [1-3]. Myocardial ischemia is known to be one
of the proposed pathophysiological mechanisms of HF
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unless otherwise stated.ischemia represents a potential therapeutic target for
some of these patients [4-6].
In recent years, cardiovascular magnetic resonance
(CMR) has established itself as an important component
to the assessment and management of patients with cor-
onary artery disease (CAD) and HF [7,8]. CMR is con-
sidered the reference method for the assessment of
global and regional ventricular function and left ven-
tricular wall mass [9]. CMR has become a robust and
widely-available tool for assessment of ischaemic scar
burden and myocardial perfusion imaging in patients
with CAD [10-12] and can be used to help elucidate
aetiology of HF [13]. However, there are no data cur-
rently available on the feasibility of perfusion CMR inl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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sion status in patients with HF can be challenging due to
LV remodelling and wall thinning, the presence of scar,
and respiratory artefacts. 3 Tesla (3 T) kt CMR perfusion
enables high spatial resolution perfusion assessment and
provides data suitable for voxel-wise quantitative ana-
lysis [14,15]. The availability of combined methods for
high-resolution imaging and voxel-wise quantitative as-
sessment may enable the use of perfusion CMR to assess
myocardial perfusion status also in patients with dilated
and remodelled ventricles, although the evidence for this
is lacking. Therefore, the aim of this study was to test
the feasibility of 3 T kt high-resolution and voxel-wise
quantitative perfusion CMR in this subgroup of patients.
Methods
We identified patients referred for perfusion CMR to as-
sess HF aetiology. Patients were then retrospectively clas-
sified on the basis of the aetiology of HF as ischaemic
(LVEF < 50% with scar arising from the subendocardium
or transmural in a location corresponding to a coronary
territory) or non-ischaemic (LVEF < 50%, either no scar or
mid-myocardial or epicardial scar with invasive coronary
angiogram confirming unobstructed epicardial coronary
arteries) [13]. A group of patients with normal LV function
(LVEF >50%) referred for suspected coronary artery dis-
ease were studied as control subjects.
All patients studied provided written consent (09/
H0802/78) and the study was conducted in accordance
with the Declaration of Helsinki.
Images were acquired on a Philips Achieva 3 T (TX)
system, equipped with a 32-channel cardiac phased array
receiver coil (Philips, Best, the Netherlands). First pass per-
fusion imaging consisted of a high-resolution kt turbo-
gradient echo sequence (imaging parameters: shortest echo
time (range 1.35 to 1.54 ms), shortest repetition time (range
2.64 to 3.12 ms), 18° flip angle, 90° saturation prepulse,
120 ms prepulse delay, typical TR 2.6 ms, typical TE 0.9 ms,
typical spatial resolution 1.2×1.2×10mm. Three short-axis
slices (basal, mid and apical) were acquired over every heart-
beat covering 16 of the standard myocardial segments (seg-
ment 17 was excluded). Stress imaging preceded rest
imaging by 14 ± 2 min (range 10 to 19 min). For stress im-
aging, 140 μg/kg/min of adenosine was administered intra-
venously for 4 min. Imaging commenced 3 min into the
infusion and continued for 1 min during the acquisition of
the images. All subjects were asked to abstain from caffeine
and caffeine-containing food and drink for at least 24 hours
before the scan, according to institutional practice.
Perfusion data were acquired during first pass injec-
tion of 0.075 mmol/kg Gadobutrol (Gadovist, Schering,
Germany) at 4 ml/minute followed by a 20 ml saline
flush. A dual bolus contrast agent scheme was used to
correct for signal saturation of the arterial input functionas previously described [16,17]. A correction map was cre-
ated from a proton density-based image based on the same
projections as the perfusion scans for correction of spatial
inhomogeneities due to surface coils [18]. The CMR scan
protocol included late gadolinium enhancement imaging for
all subjects after a top up dose of contrast agent to a total
dose of 0.2 mmol of gadolinium/kg of body weight.
Visual analysis
The studies were analyzed visually by two independent ex-
perts blinded to all other data. CMR scans were classified
visually positive for ischemia in the presence of a perfu-
sion defect (>60 degrees in either the basal or mid-
ventricular slices, or >90 degrees in the apical slice) which
was transmural, or involving ≥2 adjacent myocardial seg-
ments according to the criteria by Hussain et al. [16]. In
the case of disagreement between observers, the images
were reviewed together, and a consensus was reached.
Late gadolinium enhancement and rest perfusion scans
were then used to differentiate between stress-induced
perfusion abnormalities and scar-related perfusion defects.
Quantitative analysis
An experienced operator, blinded to visual assessment and
other clinical data, performed quantitative analysis using
software and methods developed and previously validated
against phantom and PET data [19,20]. The implementation
of high-resolution signal intensity (SI) analysis required ac-
curate respiratory motion correction and myocardial con-
tour delineation. Respiratory motion was corrected using
affine image registration by maximization of the joint correl-
ation between consecutive dynamics within an automatically
determined region of interest. A temporal maximum inten-
sity projection was calculated to serve as a feature image for
an automatic contour delineation method. The operator
then manually optimized the automatically generated con-
tours to avoid partial volume effects at the endocardial and
epicardial border as previously described [21]. Areas of sub-
endocardial dark-rim artefact occurring at the arrival of the
main bolus of contrast agent in the LV were carefully ex-
cluded from the segmentation.
Quantitative perfusion analysis was performed by
Fermi deconvolution according to the methods de-
scribed by Wilke et al. [22] and Jerosch-Herold et al.
[23] where time curves for the tissue impulse response
function, h(t), were fitted to the Fermi function with the
following analytical expression:
h tð Þ ¼ R 1
e t−τ0−τdð Þkþ1
 
u t−τdð Þ
using a Marquardt-Levenberg nonlinear least square algo-
rithm by letting k, R and τ0 vary and keeping τd fixed. In
the above equation, u(t–τd) is the unit step function. The τd
Sammut et al. Journal of Cardiovascular Magnetic Resonance  (2015) 17:13 Page 3 of 11accounts for the delay time between the appearance of the
signal in the LV blood pool and myocardial region of
interest (ROI) [24]. τ0 characterizes the width of the
shoulder of the Fermi function during which little or no
contrast agent had left the ROI. R is the index of contrast
agent influx parameter and k represents the decay rate of
h(t) due to contrast agent washout. Using the above equa-
tion, myocardial blood flow (MBF) estimates are calcu-
lated as h(t) at t=0 [25]. Myocardial perfusion reserve
(MPR) was calculated from division of stress perfusion
rate by rest perfusion rate.
In addition, voxel-wise MPR results from the epicar-
dial half (outer 50% transmural thickness) and from the
endocardial half of each segment (inner 50% transmural
thickness) were averaged and the endocardial to epicar-
dial MPR ratio (endocardial MPR/epicardial MPR) was
calculated.
Coronary angiography
Invasive coronary angiogram was performed on all patients
with ischaemic cardiomyopathy or normal LV function
within 6 months of the CMR scan.
Image quality
A visual score was given for image quality of each data-
set using a four-point scale: 1—poor, 2—fair, 3—good,
and 4— excellent. The severity of respiratory artefacts
and dark rim artefacts were also scored on a four-point
and three-point scale respectively. For respiratory arte-
facts: 1 – non-diagnostic; 2 – severe artefacts but diag-
nostic; 3 – mild artefacts; 4 – no artefacts. For dark rim
artefacts: 1- circumferential; 2- segmental; 3- absent.
Statistical analysis
Data are presented as mean and standard deviation. Group
means were compared using paired and unpaired Student
t test and 1-way ANOVA as appropriate. The statistical ana-
lyses were performed using PASW software for Macintosh
(IBM, Chicago, Illinois, version 21). Agreement between per-
fusion CMR and coronary angiography for the diagnosis of
CAD was evaluated using a Kappa agreement test. Mann-
Whitney and Chi-squared tests were used to test the qualita-
tive measurements for statistical significance, with a p value
threshold of 0.05.
Results
A total of 91 subjects were studied. This included 58 pa-
tients with HF (LVEF 39 ± 10%) and 33 patients with nor-
mal LV function (Normal LV group) (LVEF 64 ± 5%). In
the HF group, 30 patients (51.7%) had a final diagnosis of
ischaemic cardiomyopathy (ICM) and the remaining 28
subjects had a final diagnosis of non-ischaemic cardiomy-
opathy (NICM). Demographics, CMR structural findings
and haemodynamic parameters are given in Table 1.Visual analysis
In the ICM group, 25/30 (83%) patients showed evidence
of a perfusion abnormality. Of these 19/25 (76%) patients
showed stress-induced perfusion abnormalities, either ex-
tending beyond an area of scar or in an area served by a
separate coronary territory. On segmental analysis, there
were 73 segments showing stress-induced perfusion abnor-
malities (4.06 ± 2.05/patient). 90 segments showed scar-
related perfusion abnormalities (4.29 ± 2.13/patient).
In the NICM group, no visual perfusion abnormalities
were reported and 7/28 patients (for a total of 25 segments)
showed late enhancement with a non-ischaemic-pattern [13].
15/33 (46%) patients in the Normal LV group showed
stress-induced perfusion abnormalities, with a total number
of 105 positive segments (6.4 ± 4.5/patient). No patients
from the Normal LV group showed scar on late gadolinium
enhancement images.
Quantitative analysis
Stress and rest perfusion estimates
Detailed results of stress and rest quantitative analysis
are reported in Table 2.
No significant difference in visually normal segments
was observed between groups, with an average stress per-
fusion rate of 2.2 ± 1.0 ml/g/min in the ICM group, 1.9 ±
0.8 ml/g/min in the NICM group and 2.3 ± 1.3 ml/g/min
in the Normal LV group (p = 0.18).
In the ICM group, there was a significant difference in
stress perfusion rate between visually normal and abnor-
mal segments (2.2 ± 1.0 ml/g/min vs 1.8 ± 0.9 ml/g/min,
p = 0.02). The presence of ischaemic scar was associated
with significantly reduced perfusion rate compared to
visually normal segments (1.5 ± 0.8 ml/min vs 2.2 ±
1.0 ml/g/min; p = 0.005).
Within the Normal LV group, the difference in stress
perfusion rate between visually normal and abnormal seg-
ments was less pronounced and not statistically significant
(2.3 ± 1.3 ml/g/min vs 1.6 ± 0.8 ml/g/min, p = 0.08).
There was no significance difference in stress perfusion
values between the ICM and Normal LV groups in visually
abnormal segments (p = 0.47).
Examples of high-resolution, voxel-wise perfusion maps
are given in Figures 1 and 2.
MPR
Detailed results of MPR analysis are also reported in
Table 2.
No significant difference in visually normal segments was
observed between groups, with an average MPR of 2.3 ± 0.8
in the ICM group, 2.2 ± 0.9 in the NICM group and 2.6 ±
1.1 in the Normal LV group (p = 0.19).
In the ICM group, there was a significant difference in
MPR between visually normal and abnormal segments
(2.3 ± 0.8 vs 1.8 ± 0.9, p = 0.04). The presence of ischaemic
Table 1 Table showing demographic data and structural CMR findings for subjects studied
NICM group ICM group Normal LV (NLV) group P value NICM vs ICM group P value NICM vs NLV group P value ICM vs NLV group P value between all groups
Male Gender 19/28 (68%) 22/30 (73%) 22 (67%) - - - -
Age (years) 58 ± 14 63 ± 12 54 ± 18 0.78 0.77 0.08 0.79
BSA (m2) 1.86 ± 0.21 1.96 ± 0.19 1.90 ± 0.19 0.27 1.00 0.70 0.27
LV EDV (ml/m2) 102 ± 28 112 ± 33 71 ± 18 0.48 <0.0001* <0.0001* <0.0001*
LV ESV (ml/m2) 61 ± 26 73 ± 31 25 ± 8 0.16 <0.0001* <0.0001* <0.0001*
LVEF (%) 42 ± 9 37 ± 10 65 ± 4 0.06 <0.0001* <0.0001* <0.0001*
LV mass (g/m2) 73 ± 18 70 ± 18 55 ± 13 1.00 0.001* 0.006* 0.001*
RV EDV (ml/m2) 80 ± 22 74 ± 20 72 ± 18 0.88 0.39 1.00 0.30
RV ESV (ml/m2) 40 ± 20 35 ± 16 28 ± 10 0.54 0.008* 0.24 0.01*
RVEF (%) 51 ± 13 55 ± 12 62 ± 7 0.58 0.001* 0.02* 0.001*
LA area (cm2) 25 ± 7 26 ± 6 22 ± 5 1.00 0.37 0.07 0.07
RA area (cm2) 21 ± 6 21 ± 5 19 ± 4 1.00 0.77 0.76 0.43
Heart rate (bpm)
Stress 103 ± 4 104 ± 3 117 ± 7 0.06 <0.0001* <0.0001*
Rest 62 ± 5 64 ± 2 75 ± 3 0.06 <0.0001* <0.0001*
SBP (mmHg)
Stress 102 ± 6 102 ± 4 110 ± 8 0.73 <0.0001* <0.0001*
Rest 111 ± 3 109 ± 3 126 ± 7 0.09 <0.0001* <0.0001*
DBP (mmHg)
Stress 69 ± 5 69 ± 5 76 ± 3 0.43 <0.0001* <0.0001*
Rest 73 ± 4 73 ± 5 79 ± 4 0.54 <0.0001* <0.0001*
(Abbreviations: SBP- systolic blood pressure; DBP-diastolic blood pressure).
*Denotes significance.
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Table 2 Table showing rest, stress and MPR perfusion values for groups studied
Visually normal segments Visually abnormal,
non-scarred segments
Visually abnormal,
scarred segments
p-value Normal vs
non-scarred segments
p-value Normal vs
scarred segments
Stress perfusion Normal LV group (ml/g/min) 2.3 ± 1.3 1.6 ± 0.8 - 0.08 -
Stress perfusion NICM group (ml/g/min) 1.9 ± 0.8 - - - -
Stress perfusion ICM group (ml/g/min) 2.2 ± 1.0 1.8 ± 0.9 1.5 ± 0.7 0.02* 0.006*
Rest perfusion Normal LV group (ml/g/min) 0.86 ± 0.30 0.9 ± 0.4 - 0.83 -
Rest perfusion NICM group (ml/g/min) 0.90 ± 0.19 - - - -
Rest perfusion ICM group (ml/g/min) 1.0 ± 0.4 1.0 ± 0.4 0.9 ± 0.4 0.25 0.83
MPR Normal LV group 2.6 ± 1.1 1.7 ± 0.8 - 0.04* -
MPR NICM group 2.2 ± 0.8 - - - -
MPR ICM group 2.3 ± 0.8 1.8 ± 0.9 1.7 ± 0.7 0.04* 0.004*
*Denotes significance.
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Perfusion image Overlay image Perfusion maps
Figure 1 Perfusion images from a HF patient with a circumflex coronary artery lesion causing a perfusion abnormality extending from
base (A) to mid (B) to apical (C) level. Images seen vertically on the right show the perfusion maps corresponding to the ventricular level, the
central column shows superimposed images. Note that there is mild respiratory artifact (white arrows) and that dark rim artifact seen in the apical
inferoseptal wall (orange arrow).
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compared to visually normal segments (1.68 ± 0.08 vs 2.3 ±
0.8, p = 0.004).
Similarly, within the Normal LV group, the difference
in MPR between visually normal and abnormal segmentsFigure 2 Perfusion images from three different HF patients with imag
images in the centre. Row A shows thinning of the mid inferior wall with
in the territory of the LAD. Row C shows homogenous perfusion in a patiewas statistically significant (2.6 ± 1.1 vs1.7 ± 0.8, p =
0.04).
There was no significance difference in MPR values
between the ICM and Normal LV groups in visually ab-
normal segments (p = 0.62).e on the left, perfusion map on the right and superimposed
peri-infarct ischemia in the territory of the RCA. Row B shows ischemia
nt with thinned and dilated ventricle.
Table 3 Table showing results of coronary angiography versus perfusion CMR results for patients in ICM and Normal LV groups
LAD territory CX territory RCA territory
Group CAD on
angio
LGE
only
iPD
(no LGE/beyond LGE)
Kappa
(significance)
CAD
on angio
LGE
only
iPD
(no LGE/beyond LGE)
Kappa
(significance)
CAD on
angio
LGE
only
iPD
(no LGE/beyond LGE)
Kappa
(significance)
ICM
group
25/30
(83%)
12/25
(48%)
11/25 (44%) 0.462
(p = 0.003*)
11/30
(37%)
4/11
(36%)
4/11 (16%) 0.603 (<0.001*) 13/30
(43%)
9/13
(69%)
6/13 (46%) 0.718
(p = <0.001*)
Normal
LV group
16/33
(48%)
0/33 6/16 (37.5%) 0.382 (0.005*) 11/33
(33%)
0/11 6/11 (55%) 0.615 (<0.001*) 13/33
(39%)
0/13 6/13 (46%) 0.510
(p = 0.001*)
(Abbreviations: angio - invasive coronary angiogram; CAD - coronary artery disease; iPD- inducible perfusion defect; LAD- left anterior descending artery; Cx- circumflex artery; RCA- right coronary artery, LGE-late
gadolinium enhancement).
*Denotes significance.
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There was no significant difference in the endo-epi MPR
ratio in visually normal segments across groups with an
endo-epi MPR ratio of 1.05 ± 0.16 in ICM patients,
1.02 ± 0.04 in NICM patients and 1.00 ± 0.06 in Normal
LV patients (p = 0.57).
There was a significant difference in endo-epi MPR ra-
tio between visually normal and visually abnormal non-
scarred segments in both the ICM and Normal LV
groups (ICM group: 1.04 ± 0.09 versus 0.96 ± 0.12 re-
spectively, p = 0.02; Normal LV group: 1.00 ± 0.05 versus
0.93 ± 0.06 respectively, p = 0.02).
Coronary angiography
The results of invasive coronary angiography and perfu-
sion CMR in relation to coronary artery territories, in-
cluding Kappa results are detailed in Table 3.
Image quality
Detailed results of overall image qualitative assessment,
respiratory artefacts and dark rim artefacts are presented
in Table 4 and Figure 3, with no significant differences
observed between groups. The average angular extent of
dark rim artefact was 27° (range 9-41°).
Discussion
This study has several novel findings. Most importantly,
it demonstrates the feasibility of quantitative first-pass
perfusion analysis in patients with heart failure using a
combination of high-resolution kt 3 T acquisition
methods and high-resolution voxel-wise quantification.
There were significant differences of MPR between visu-
ally normal and abnormal segments in both ICM and
Normal LV groups. In the ICM group stress perfusion
values were also statistically significant between visually
normal and abnormal segments. However, this was not
the case in the Normal LV group. This could be ex-
plained by the relatively low number of subjects positive
for ischemia included in the study and is in keeping with
previous validation studies that compared CMR perfu-
sion and PET, showing good correlation for MPR values
and weaker correlation for absolute stress perfusion
values. This may relate to differences in the methods
used for quantification such as the tracer properties,
model assumptions, fitting methods and parameterTable 4 Table showing results of the Chi-squared tests for
qualitative assessment of image quality showing no
significant differences between groups
Chi-square P value
Overall image quality 2.559 0.6342
Respiratory artefacts 5.359 0.2524
Dark rim artefacts 1.863 0.7609constraints. MPR cancels out a degree of variability and
this may help explain our results [26].
CMR is now well established for the evaluation of pa-
tients with coronary disease and heart failure. Perfusion
CMR is increasingly used to determine aetiology of heart
failure and to plan patient management. At the same
time, CMR is now well established for the evaluation of
patients with CAD and ischemia detection is rapidly
becoming one of the main indications for CMR examin-
ation [27]. Studies have also shown that even in non-
ischaemic cardiomyopathy the presence of ischemia has
implications for the occurrence of adverse events
[5,6,28].
Perfusion CMR has been previously shown to be at least
as accurate as nuclear perfusion imaging in patients with
angina [12,29,30] and quantitative perfusion CMR has
been validated against FFR [31,32], microspheres [22,33],
Single Photon Emission Computed Tomography (SPECT)
[34] and Positron Emission Tomography (PET) [20].
Within the field of perfusion CMR, several technical
developments have refined the sequences. The use of an
advanced sequence such as kt sensitivity encoding allows
considerable improvement in spatial resolution with im-
proved image quality, signal-to-noise, contrast-to-noise
and reduction in the transmural extent of dark-rim arte-
facts, particularly at 3 T [15]. The advantages of the kt
sequence in comparison with standard perfusion CMR
sequences when using visual assessment has been dem-
onstrated in patients with normal LV function [14,35].
To our knowledge, there are no previous studies fo-
cusing on perfusion in patients with heart failure using
CMR. Only a few studies, using PET, have been per-
formed specifically exploring perfusion abnormalities in
patients with HF and have produced conflicting results
[36-38]. Van Den Heuvel et al. studied a group of NICM
patients using PET and showed a similar perfusion rate
at rest but reduced global myocardial perfusion reserve
(MPR) versus a group of healthy controls [36]. In con-
trast, Neglia et al. showed a reduced MPR at rest as well
as during pacing and pharmacological stress in patients
with NICM [38]. The concept that even in NICM, the
presence of silent ischemia may contribute to progres-
sive impairment of LV function was supported by find-
ings by a study by Tio et al. patients with NICM were
assessed with PET and dobutamine stress [39]. They
found that MPR was significantly higher in segments
with higher contractile reserve and lower in the seg-
ments which did not change or deteriorated with stress.
Non-invasive assessment of myocardial perfusion in
patients with HF can be challenging for a number of rea-
sons. Foremost, in cases of advanced HF the LV wall is
often thinner and remodeled, requiring higher spatial
resolution to reliably identify subendocardial areas of
stress-induced ischemia or areas of peri-infarct ischemia.
Figure 3 Figure showing the relative scores for image quality, respiratory artefacts and dark rim artefacts according to group.
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quantitative perfusion assessment. However, it is limited
by the intrinsically lower spatial resolution and this
might become an important limiting factor for the as-
sessment of dilated and remodelled ventricles.
Perfusion CMR, and in particular 3 T kt, offers
higher spatial resolution and arguably is best placed to
identify areas of ischemia in these patients. In addition,
the advantage of CMR over other techniques to dir-
ectly visualise scar enables more precise assessment of
peri-infarct ischemia. This reduces the risk of includ-
ing scarred areas in segmental averages of perfusion.
Perfusion rate in areas of scar was found to be reduced
which, if included in the analysis, could result in false
positive ischemia results.
We observed a non-significant trend towards lower per-
fusion rates in visually normal segments of patients with
NICM, which would be in keeping with the results previ-
ously obtained by PET. However, this comparison is beyond
the scope of the study and would need to be addressed in
future work.
Importantly, our results demonstrate a significant endo-
cardial-epicardial MPR ratio in ischaemic segments, even in
patients with HF who have thinned and remodelled ventri-
cles. This is in keeping with findings of a study by Parodi
et al. where microspheres were injected into hearts of pa-
tients at time of transplantation, demonstrating the presence
of a perfusion gradient in the presence of extensive LV re-
modelling [40]. To our knowledge, our data are the first to
show that non-invasive quantification of myocardial perfu-
sion in multiple independent layers of myocardium is feas-
ible also in this group of patients.
Perfusion assessment in patients with HF can be further
complicated by a well-recognised irregularity in respiratory
motion and reduced tolerance to breath-holding which can
result in a reduction in image quality [41-43]. These respira-
tory artefacts are likely to affect kt sequences, used in this
study, more significantly than other perfusion sequences.
We did not observe this effect in our study, which may be a
reflection of good patient coaching and careful selection of
the time for the breath hold command.Limitations of the study
1) This is a feasibility study. No reference standard except
for visual assessment was used. However, visual
assessment is considered the clinical diagnostic
standard for perfusion CMR evaluation and extensive
validation is available against Fractional Flow Reserve
(FFR), invasive angiography, Single Positron Emission
Computed Tomography (SPECT) and PET.
2) Though we were able to compare our findings with
invasive coronary angiography, this serves as a
limited reference method in the absence of invasive
functional assessment of coronary flow reserve.
Furthermore, the variability in coronary anatomy in
terms of territory supplied, may underestimate the
degree of correlation between the two techniques.
3) Results might not be easy to generalise to other
CMR sequences and field-strengths, or to standard
(segmental) quantitative analysis methods. The
quantification process may need to be adjusted for
other field strengths and perfusion sequences and
this could form part of future work.
Conclusion
This study demonstrates that the combination of 3 T kt
high-resolution perfusion CMR with high-resolution voxel-
wise quantitative analysis appears feasible in this group of
heart failure patients. This approach allows additional infor-
mation gained from improved spatial resolution to be pre-
served, a feature that is of crucial importance in thinned and
remodeled ventricles.
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